Estimaciones de analistas de Wall Street para Monopar Therapeutics Inc. (MNPR): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-12 | $-0.86 | ||
| 2026-08-12 | $-0.62 | $-0.64 | +3.6% |
| 2026-05-14 | $-0.46 | $-1.06 | +56.6% |
| 2026-03-27 | $-0.61 | $-0.51 | -19.1% |
| 2025-11-13 | $-0.48 | $-0.46 | -4.3% |
| 2025-08-12 | $-0.35 | $-0.47 | +25.5% |
| 2025-05-13 | $-0.38 | $-0.65 | +41.5% |
| 2025-03-31 | $-2.23 | $-0.36 | -519.4% |
Ratios de valoración
| Precio / Valor contable | 6.62 |
| EV / EBITDA | -37.08 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| I+D | $280355 | $935319 | $1.8M | $2.0M | $4.1M | $6.5M | $7.6M | $5.6M | $13.0M | $9.90B |
| Generales y Administrativos | $912474 | $1.2M | $1.6M | $2.4M | $2.4M | $2.6M | $2.9M | $3.2M | $3.2M | $6.80B |
| Gastos Operativos | $1.2M | $16.6M | $3.4M | $4.3M | $6.5M | $9.1M | $10.5M | $8.8M | $16.2M | $16.7M |
| Beneficio Operativo | -$1.2M | -$16.6M | -$3.4M | -$4.3M | -$6.5M | -$9.1M | -$10.5M | -$8.8M | -$16.2M | -$16.7M |
| EBITDA | $8032 | -$16.6M | 0 | -$4.2M | 0 | -$9.1M | -$10.5M | -$8.4M | -$15.6M | -$13.7M |
| Gastos por Intereses | $7232 | $48255 | $103215 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$1.2M | -$16.6M | -$3.3M | -$4.2M | -$6.3M | -$9.1M | -$10.5M | -$8.4M | -$15.6M | -$13.7M |
| Impuestos | $800 | 0 | -$71615 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$1.2M | -$16.6M | -$3.2M | -$4.2M | -$6.3M | -$9.1M | -$10.5M | -$8.4M | -$15.6M | -$13.7M |
| BPA | $-0.12 | $-1.59 | $-0.31 | $-0.40 | $-0.58 | $-0.73 | $-0.83 | $-0.58 | $-1.36 | $-1.85 |
| BPA Diluido | $-0.12 | $-1.59 | $-0.31 | $-0.40 | $-0.58 | $-0.73 | $-0.83 | $-0.58 | $-1.36 | $-1.85 |
| Acciones en Circulación (Diluidas) | $9.9M | $10.4M | $10.4M | $10.6M | $11.0M | $12.5M | $12.7M | $14.5M | $11.5M | $7.4M |
Precio
| Precio | $101.45 |
| Capitalización | $680M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: AKBA · BCYC · CMPX · FDMT · FULC · GOSS · KALV
Explorar sector: Healthcare · Biotechnology
Más secciones de MNPR: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones